Search terms
Results 1 - 1 of 1 - ordered by :

Dual antiplatelet therapy (DAPT, a combination of aspirin and a P2Y12 inhibitor), typically for up to 1 year, has been shown to be of benefit in patients undergoing percutaneous coronary intervention ...

European Heart Journal, Parker, William A.E., Storey, Robert F.

Date : 21/01/2016 Item size : 181103 bytes